“For me to deal with a Doctor of Pharmacy, for her to give me information on each of our phone calls—I felt much better able to advocate for myself with my MD. I was able to get off some of my meds, too.”
— Sarah, health plan member MOBE participant
Client: Not-for-profit, regional mid-sized health plan
Size: 200K+ members, including fully-insured commercial and individual
Selected for MOBE: 25-50K members
Randomized Control Trial (RCT): Members assigned to performance and control groups
A randomized controlled trial (RCT) proved MOBE's impact, prompting the health plan to double program eligiblity.
Like most, this health plan faced rising costs, and its organizational cost-of-care leader needed to accomplish measurable savings goals quickly while confidently demonstrating program attribution for skeptical stakeholders. Its patient-centered care resources were constrained to the highest-cost and highest-risk members, and its engagement efforts were narrowly focused, which limited its ability to maximize reductions in the total cost of care—especially with any speed.
Partnering with MOBE addressed two critical challenges for the plan: program attribution and rising costs. MOBE’s gold-standard RCT methodology and guaranteed cost-savings model eliminated risk, allowing the plan to count on savings up front.
Using proprietary AI analytics, MOBE identified a rising-risk, multi-chronic population, mid-tier claimants caught in a cycle of system overutilization. These members were split into two groups: one receiving MOBE’s personalized guidance and medication optimization, and a control group. Both had access to the same plan benefits, subject to the same system changes, with MOBE as the only difference.
The first performance period delivered such strong outcomes that 10,000 members were added to the performance group, eligible for MOBE. The result? 32.4% engagement and significant savings across three years.
MOBE’s whole-person, cross-condition solution complemented the plan’s existing offerings without competition or redundancy by focusing on a unique subset of continual care seekers—those representing untapped savings.
Read Milliman’s report validating MOBE’s methodology for measuring claims cost savings with RCT.
— Sarah, health plan member MOBE participant
participant satisfaction rate within the first year
The health plan realized three consecutive performance periods of increasingly positive population health outcomes and claims-cost savings.
See how a Fortune 500 employer reduced projected health care spend by 13.9% and generated $1.9 million in savings with MOBE's whole-person, cross-condition approach.